CENTENNIAL, Colo.--(BUSINESS WIRE)--Inhibiton Therapeutics, Inc. (OTCBB: IHBT) (“Inhibiton” or the “Company”) announced today that it is moving forward with its previously announced acquisition of HPI Partners, LLC (“HPIP”) and its operating subsidiary AlumiFuel Power, Inc. (“API”) of Philadelphia, Pennsylvania. HPIP, through API, is an alternative energy company working to commercialize a process for generating hydrogen gas and steam on-site and on-demand for multiple niche applications. HPIP circulated to its members yesterday a package of documents for them to execute and return for the closing.
